These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 446907)

  • 1. Maintenance of basal plasma glucose and insulin concentrations in maturity-onset diabetes.
    Holman RR; Turner RC
    Diabetes; 1979 Mar; 28(3):227-30. PubMed ID: 446907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The basal plasma glucose: a simple relevant index of maturity-onset diabetes.
    Holman RR; Turner RC
    Clin Endocrinol (Oxf); 1981 Mar; 14(3):279-86. PubMed ID: 7021010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. betacell function during insulin or chlorpropamide treatment of maturity-onset diabetes mellitus.
    Turner RC; Holman RR
    Diabetes; 1978; 27 Suppl 1():241-6. PubMed ID: 344115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus.
    Garvey WT; Revers RR; Kolterman OG; Rubenstein AH; Olefsky JM
    J Clin Endocrinol Metab; 1985 Mar; 60(3):559-68. PubMed ID: 3882736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal and glucagon-stimulated plasma C-peptide concentrations in healthy dogs, dogs with diabetes mellitus, and dogs with hyperadrenocorticism.
    Montgomery TM; Nelson RW; Feldman EC; Robertson K; Polonsky KS
    J Vet Intern Med; 1996; 10(3):116-22. PubMed ID: 8743209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
    Al-Waili N
    Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic analysis of the response of plasma glucose, insulin, and C-peptide to glucagon injection in normal and diabetic subjects.
    Turco G; Brossa C; D'Alberto M; Regis G; Segre G; Bianchi E; Bruni B; Gamba S
    Diabetes; 1981 Aug; 30(8):685-93. PubMed ID: 7018972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12.
    Byrne MM; Sturis J; Menzel S; Yamagata K; Fajans SS; Dronsfield MJ; Bain SC; Hattersley AT; Velho G; Froguel P; Bell GI; Polonsky KS
    Diabetes; 1996 Nov; 45(11):1503-10. PubMed ID: 8866553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.
    Gutniak M; Orskov C; Holst JJ; Ahrén B; Efendic S
    N Engl J Med; 1992 May; 326(20):1316-22. PubMed ID: 1348845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects.
    Sherwin RS; Fisher M; Hendler R; Felig P
    N Engl J Med; 1976 Feb; 294(9):455-61. PubMed ID: 1246330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief, irregular oscillations of basal plasma insulin and glucose concentrations in diabetic man.
    Lang DA; Matthews DR; Burnett M; Turner RC
    Diabetes; 1981 May; 30(5):435-9. PubMed ID: 7014311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma insulin and C-peptide responses to oral glucose in newly diagnosed diabetics in north-western Tanzania.
    Ahren B; Corrigan CB; Alberti KG
    East Afr Med J; 1988 Dec; 65(12):847-51. PubMed ID: 3069450
    [No Abstract]   [Full Text] [Related]  

  • 13. Basal normoglycemia attained with chlorpropamide in mild diabetes.
    Holman RR; Turner RC
    Metabolism; 1978 May; 27(5):539-47. PubMed ID: 565457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The insulin response to intravenous fructose in maturity-onset diabetes mellitus and in normal subjects.
    Lawrence JR; Gray CE; Grant IS; Ford JA; McIntosh WB; Dunnigan MG
    Diabetes; 1980 Sep; 29(9):736-41. PubMed ID: 7002688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations.
    Turner RC; Holman RR; Matthews D; Hockaday TD; Peto J
    Metabolism; 1979 Nov; 28(11):1086-96. PubMed ID: 386029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes: The quest for basal normoglycaemia.
    Holman RR; Turner RC
    Lancet; 1977 Feb; 1(8009):469-74. PubMed ID: 65573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma C-peptide response to arginine in insulin-dependent diabetic subjects.
    Giugliano D; Luyckx AS; Lefebvre PJ
    J Endocrinol Invest; 1980; 3(1):19-23. PubMed ID: 6989887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance and decreased insulin response to glucose in lean type 2 diabetics.
    Wajngot A; Roovete A; Vranić M; Luft R; Efendić S
    Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4432-6. PubMed ID: 6750603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of muscular exercise on plasma C-peptide and insulin in obese non-diabetics and diabetics, type II.
    Krotkiewski M; Górski J
    Clin Physiol; 1986 Dec; 6(6):499-506. PubMed ID: 3539463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes.
    DeFronzo R; Deibert D; Hendler R; Felig P; Soman V
    J Clin Invest; 1979 May; 63(5):939-46. PubMed ID: 376552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.